Skip to main
University-wide Navigation

Policy for UK Investigator-initiated Clinical Trials

New policy for clinical trial registration and results dissemination in ClinicalTrials.gov.

Markey networks bring latest clinical trials home to patients

Cancer patient Debra Kantosky was offered the opportunity to participate in a clinical trial to determine if allowing patients to choose their own tobacco cessation treatment and level of coaching helps them quit.

Markey’s Community Advisory Board advocates for research advances

The CAB meets regularly throughout the year to offer input on the Kentucky Cancer Needs Assessment, Markey’s strategic plan, research priorities and outreach activities.

Clinical trials make discovery happen at UK

At the University of Kentucky, clinical trials are essential to providing the most advanced care to our patients and communities.

Ky. attorney defies brain cancer odds through Markey clinical trial

Following surgery to remove a tumor from his brain, David Higdon was offered the opportunity to participate in an NIH-funded clinical trial.

Research Advancing Kentucky: Providing crucial supports for researchers

With NIH support, Katherine Hartmann describes the vital work of the UK Center for Clinical and Translational Science (CCTS) for UK researchers and Kentucky communities.

Markey clinical trials offer ‘latest and greatest’ cancer treatments

During a recent roundtable discussion, Zhonglin Hao and Eddy Yang shared the importance of clinical trials and how they play a significant role in changing how providers approach cancer care.

UK Begins 1st Clinical Trial in the World for Newly Discovered Form of Dementia

The world’s first clinical trial for a form of dementia identified in 2019 is officially underway by researchers at the University of Kentucky's Sanders-Brown Center on Aging.

Results of Johnson & Johnson COVID-19 Vaccine Trial Announced

The Phase 3 randomized, double-blind, placebo-controlled clinical trial was designed to evaluate the safety and efficacy of a single vaccine dose of the Janssen investigational COVID-19 vaccine candidate versus placebo. Approximately 45,000 people participated worldwide. The combined UK, Baptist and Norton site was among the top enrolling sites in the world.

Markey Study Shows Kentucky Endometrial Cancer Patients Have Higher Rates of DACH1 Mutation

A new study by UK Markey Cancer Center researchers shows that DACH1 mutations are prevalent in Kentucky patients with endometrial cancer, suggesting that DACH1 may be a candidate biomarker for future trials with immunotherapy.

Filter News